Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/7383
Title: | Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice | Authors: | Canet, Geoffrey Gratuze, Maud Zussy, Charleine Bouali, Mohamed Lala Diaz, Sofia Diego Rocaboy, Emma Laliberté, Francis Khoury, Noura El Tremblay, Cyntia Morin, Françoise Calon, Frédéric Hébert, Sébastien S Julien, Carl Planel, Emmanuel |
Affiliations: | Department of Psychology | Keywords: | 3xTg-AD mice Alzheimer's disease Amyloid-β Blood-brain-barrier Diabetes mellitus Insulin deficiency Streptozotocin Tau phosphorylation |
Issue Date: | 2024-05-09 | Publisher: | Elsevier | Part of: | Neurobiology of Disease | Volume: | 198 | Abstract: | Alzheimer's disease (AD) is a multifactorial neurodegenerative disease with a complex origin, thought to involve a combination of genetic, biological and environmental factors. Insulin dysfunction has emerged as a potential factor contributing to AD pathogenesis, particularly in individuals with diabetes, and among those with insulin deficiency or undergoing insulin therapy. The intraperitoneal administration of streptozotocin (STZ) is widely used in rodent models to explore the impact of insulin deficiency on AD pathology, although prior research predominantly focused on young animals, with no comparative analysis across different age groups. Our study aimed to fill this gap by analyzing the impact of insulin dysfunction in 7 and 23 months 3xTg-AD mice, that exhibit both amyloid and tau pathologies. Our objective was to elucidate the age-specific consequences of insulin deficiency on AD pathology. STZ administration led to insulin deficiency in the younger mice, resulting in an increase in cortical amyloid-β (Aβ) and tau aggregation, while tau phosphorylation was not significantly affected. Conversely, older mice displayed an unexpected resilience to the peripheral metabolic impact of STZ, while exhibiting an increase in both tau phosphorylation and aggregation without significantly affecting amyloid pathology. These changes were paralleled with alterations in signaling pathways involving tau kinases and phosphatases. Several markers of blood-brain barrier (BBB) integrity declined with age in 3xTg-AD mice, which might have facilitated a direct neurotoxic effect of STZ in older mice. Overall, our research confirms the influence of insulin signaling dysfunction on AD pathology, but also advises careful interpretation of data related to STZ-induced effects in older animals. |
URI: | https://scholarhub.balamand.edu.lb/handle/uob/7383 | ISSN: | 09699961 | DOI: | 10.1016/j.nbd.2024.106526 | Ezproxy URL: | Link to full text | Type: | Journal Article |
Appears in Collections: | Department of Psychology |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.